Keensight Capital acquired Symeres in 2021 Exemplify BioPharma provides integrated small molecule chemistry manufacturing and controls services to pharmaceutical and biotech partners Symeres is a ...
Symeres has acquired Exemplify BioPharma for an undisclosed price, marking the CRO and CDMO’s second purchase in the U.S. in 2022. In April, Netherlands-based Symeres snapped up U.S. lipid maker and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results